3rd Annual “Induced Pluripotent Stem Cells: Production and Utility in Regenerative Medicine"

Add to your list(s) Download to your calendar using vCal

• Lyn Healy is the senior Stem Cell Biologist at the UK Stem Cell Bank
• Monday 23 July 2012, 09:00-17:00
• The Stevenage Bioscience Catalyst,Stevenage, Hertfordshire, UK.

If you have a question about this talk, please contact Dr Shara Cohen.

Human induced pluripotent stem cells (hiPSCs) generated by reprogramming somatic cells represent an unique opportunity for regenerative medicine. Indeed, hIPSCs can proliferate indefinitely in vitro while maintaining the capacity to differentiate into broad number of cell type. Therefore, hIPSCs could be used to produce an infinite quantity of cell type with a clinical interest. In addition, hIPSCs could enable the production of patient specific cell types which are fully immuno-compatible with the original donor thereby avoiding the need for immune suppressive treatment during cell based therapy. However, recent reports have suggested that epigenetic and genetic anomalies associated with direct reprogramming technology could limit the interest of hIPSCs for in vivo use.

This 3rd Annual event will review the drawbacks and advantages of hIPSCs for diverse types of clinical applications.

http://www.regonline.co.uk/2012londonstemcellevent

This talk is part of the Euroscicon series.

This talk is included in these lists:

• Euroscicon
• The Stevenage Bioscience Catalyst,Stevenage, Hertfordshire, UK

Note that ex-directory lists are not shown.